Medically reviewed by Dr. Ploy, MD, Qualified Peptide Therapy Doctor, Board Certified in Family Medicine, Regenerative & Longevity Medicine Specialist , licensed by the Medical Council of Thailand.
Last reviewed: May 2026
Ipamorelin and CJC-1295 are the most commonly searched growth hormone peptide combination in the world, and also one of the most misunderstood. People hear “growth hormone” and assume it means injecting HGH. It does not. This combination works in a very different, more physiologic way, and understanding that difference is the key to using it responsibly.
This guide explains what each peptide does, why they are almost always used together, the difference between the DAC and no-DAC versions of CJC-1295, the benefits people actually report and how long they take, what needs monitoring, who should be cautious, and why clinical-grade sourcing is non-negotiable. At Peptides Thailand, the aim is a structured, monitored plan, not a quick fix.
What Each Peptide Does
These two peptides are popular together because they act on the same system from two different angles. One raises the underlying signal, and the other delivers a clean pulse on top of it.
CJC-1295
CJC-1295 is a growth hormone releasing hormone (GHRH) analog. In simple terms, it increases the amount of growth hormone the pituitary gland is prompted to release. It supports the upstream signal rather than introducing growth hormone directly into the body.
Ipamorelin
Ipamorelin is a selective growth hormone secretagogue, sometimes described as a ghrelin-receptor agonist. It triggers a clean, targeted pulse of growth hormone release with a favourable selectivity profile, meaning it is studied for stimulating GH release without strongly affecting other hormones such as cortisol or prolactin.
Put together, CJC-1295 raises the baseline signal and Ipamorelin delivers the pulse, which is why they are studied as a combination that supports the body’s own growth hormone secretion in a more natural, pulsatile rhythm.
Ready to discuss your protocol?
A 30-minute video consultation covers your goals, current health and the peptides most relevant to you. Available across Thailand.
CJC-1295 With DAC vs Without DAC
One nuance that confuses a lot of people searching online: CJC-1295 comes in two forms, and they behave very differently.
With DAC. The DAC version (Drug Affinity Complex) binds to albumin in the blood, which dramatically extends its half-life. The result is a sustained, longer-lasting elevation in growth hormone signaling. It is convenient for less frequent dosing, but the constant elevation is less like the body’s natural pattern.
Without DAC. The no-DAC version, often called modified GRF 1-29, is shorter acting. It produces a sharper, more pulse-like effect that fades quickly, which is closer to how the body naturally releases growth hormone in bursts.
Many clinicians favour the shorter-acting, pulsatile approach when pairing with Ipamorelin, precisely because mimicking natural pulses is generally considered more physiologic. Which form suits you is a clinical decision based on your goals, not something to guess at from a forum thread.
This Is Not the Same as Taking HGH
This is the single most important concept. Injecting growth hormone directly overrides your body’s own regulation and shuts down some of its natural production. Ipamorelin and CJC-1295 instead prompt your own pituitary gland to release growth hormone, working within the body’s feedback systems, including the natural brakes that prevent runaway levels.
That distinction is why this approach is generally considered more physiologic. But “more physiologic” does not mean “no oversight needed.” It still warrants a clear rationale, appropriate bloodwork, and monitoring over time.
The Benefits People Actually Report
The combination is most often discussed in relation to three outcomes. It helps to be honest about both what people notice and how long it tends to take.
Sleep Quality
This is usually the first thing people notice, often within the first one to three weeks. A large share of natural growth hormone release happens during deep sleep, and many users report deeper, more restorative sleep early on. Better sleep then supports almost everything else: recovery, mood, appetite regulation, and metabolic health.
Recovery and Resilience
Because growth hormone signaling is involved in tissue repair, the combination is commonly considered by people whose recovery has slowed relative to their training effort. This tends to build over roughly four to eight weeks, and it assumes protein intake, programming, and sleep are already reasonable.
Body Composition Over Time
Supported growth hormone signaling is associated with lean mass maintenance and fat metabolism. This is a slow, gradual effect rather than a dramatic one, usually discussed over three months or longer, and it depends heavily on training and nutrition doing their part.
None of these are guaranteed. They are patterns that may emerge when the protocol is paired with the fundamentals that actually drive results.
What to Realistically Expect
A simple timeline helps set expectations:
| Timeframe | What people often report |
|---|---|
| Weeks 1 to 3 | Deeper, more restorative sleep |
| Weeks 4 to 8 | Improved recovery and a sense of resilience |
| Month 3 and beyond | Gradual body composition shifts, alongside training and nutrition |
These are general patterns from a population, not a promise for any one person. Some people respond strongly, others modestly.
Side Effects and Tolerability
No active compound is free of potential side effects. Reported effects with this class include mild water retention, transient tingling or numbness in the hands, a brief flushing or head-rush sensation after injection, and increased hunger with some secretagogues. Ipamorelin is considered one of the more selective options, which is part of why it is favoured over older, less selective GHRPs that more strongly raised cortisol and prolactin.
A physician watches for these effects, checks how IGF-1 and glucose respond, and adjusts the plan. Self-running a protocol means none of that feedback exists.
Start with a full metabolic assessment.
Your physician reviews your baseline labs before recommending any protocol. No guesswork, no generic dosing schedules.
Who Tends to Be a Good Candidate
This combination is most often considered for adults who recognise one or more of these patterns:
- Poor or non-restorative sleep
- Recovery that lags behind training effort
- Age-related shifts in body composition
- A preference for monitored, physician-guided support over self-experimentation
It is not automatically right for everyone, and it should not replace evaluation for thyroid imbalance, sleep disorders, stress load, or other drivers that can produce the same symptoms.
Who Should Be Cautious or Avoid It
Growth hormone peptides are generally not appropriate during pregnancy, for people with active or recent cancer (because growth signaling and cell growth are linked), or where there are certain pituitary or metabolic conditions. People with diabetes need particular care because growth hormone can influence insulin sensitivity. This is general information rather than personal medical advice, and an evaluation is the only way to know what fits your case.
What Needs Monitoring
A responsible protocol is a monitored protocol. Depending on the clinical picture, that typically includes:
- Relevant baseline bloodwork before starting
- IGF-1 dynamics where appropriate, so the response can be tracked rather than assumed
- Glucose and metabolic markers where relevant
- Follow-up adjustments based on results, tolerability, and goals
- A clear plan for duration and review rather than indefinite open-ended use
This is also why CJC-1295 and Ipamorelin are often discussed alongside related options like Tesamorelin for visceral fat and metabolic goals. For a side-by-side on the secretagogues themselves, see our CJC-1295 vs Ipamorelin comparison.
Product Quality and Sourcing
Growth hormone peptides are injectable and used over several months, which makes sourcing especially important. Research-grade products are manufactured as laboratory chemicals, not for human therapeutic use, and carry real risks around purity, sterility, and dosing accuracy. Reconstituting an injectable from an unverified vial and using it nightly for months is exactly the scenario where quality cannot be an afterthought.
Peptides Thailand uses clinical-grade sourcing with verifiable Certificates of Analysis (COAs). If a batch cannot be verified, it does not belong in a physician-guided plan. For the full picture, read Clinical-Grade vs Research-Grade Peptides.
The Fundamentals Still Matter Most
Even a well-designed GH peptide protocol underperforms without the basics:
- Consistent, sufficient sleep (the protocol amplifies good sleep habits, it does not replace them)
- Protein intake and resistance training
- Stress and alcohol management
- Thyroid and metabolic markers reviewed where relevant
If the fundamentals are ignored, the protocol becomes guesswork rather than strategy.
Availability Across Thailand
Peptides Thailand supports patients through in-person care and telemedicine consultations where appropriate. We work with patients in Chiang Mai and Phuket, and commonly support individuals based in Bangkok, Pattaya, Hua Hin, Koh Samui, Chiang Rai, Udon Thani, and Krabi, as well as international patients visiting Thailand for medical care.
A Clinical Next Step
If your sleep, recovery, or body composition is not matching your effort, it is reasonable to discuss whether an Ipamorelin and CJC-1295 protocol fits your case, under physician guidance, with clinical-grade sourcing and proper monitoring.
The goal is not “growth hormone.” It is supporting your own physiology in a measured, monitored way that fits your goals.
